Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-024577
Filing Date
2010-04-30
Accepted
2010-04-30 17:20:13
Documents
2
Period of Report
2010-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2152
2 EX-24 DOCUMENT attachment1.htm EX-24.3_328611 1894
  Complete submission text file 0001209191-10-024577.txt   5766
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVE., SUITE 950 NASHVILLE TN 37203
Business Address
Jones James (Reporting) CIK: 0001490829 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 10788880